Abbvie Inc
NYSE: ABBV
$189.45
-$0.23 (-0.1%)
Closing Price on October 29, 2024
ABBV Articles
AbbVie saw its shares pull back on Thursday after it reported less than favorable midstage results for its relapsed/refractory small cell lung cancer trial.
Published:
Last Updated:
Jefferies has made a big move by adding a top retail company to its well-respected Franchise Picks list of stocks to Buy.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.
Published:
Last Updated:
These five stocks come with upward earnings revisions and the potential for rising dividends. They all make good sense for investors looking for stocks ideas as we get closer to the second quarter.
Published:
Last Updated:
These were 13 stock buyback and dividend hike announcements from the week of February 16 that were simply too large to be ignored.
Published:
Last Updated:
AbbVie is joining the companies raising their shareholder rewards. The pharmaceutical products maker has announced how it will further commit to previously forecast moves.
Published:
Last Updated:
The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
While not the most exciting companies in the world, these five Dividend Aristocrats will certainly hold up much better than others should the market take a deep dive.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Monday include AbbVie, Apple, Exact Sciences, Freeport-McMoran, Laboratory Corp and Splunk.
Published:
Last Updated:
Friday was a positive day for the U.S. markets. We are currently in the midst of the fourth quarter earnings season and so far it has been very positive for the markets, pushing all of the exchanges...
Published:
Last Updated:
AbbVie reported better-than-expected fourth-quarter financial results before the markets opened on Friday.
Published:
The January 12 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
With the market trading at very extended valuations, and the S&P 500 on the longest streak ever without a 5% correction, it may make sense to move to some safer higher ground.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Netflix, Ford, AbbVie and other top companies reporting their latest quarterly results in the coming week.
Published:
Last Updated: